Head-to-head · Value Score
GOAL.MD vs Ro
Two GLP-1 deals, scored on the same six factors. GOAL.MD lands a Value Score of 81, Ro a 74. Here's who gives you the honest lower price — and where each one bites back.
GOAL.MD
#56 · Grade B · Good Value
Est. first month
$179/mo
Save ~87% vs brand-nameRo
#153 · Grade C+ · Watch List
Est. first month
Not disclosed
The verdict
GOAL.MD takes it on Value Score, 81 to 74 — an est. $179/mo first month, with no teaser step-up baked in. Ro isn't out of it: Patients who want brand-name access and insurance navigation more than a visible low price.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | GOAL.MD | Ro |
|---|---|---|
| Value Score | 81 (B) | 74 (C+) |
| Est. first month | $179/mo | Not disclosed |
| Save vs brand-name | ~87% | — |
| Semaglutide | $179/mo | Not disclosed |
| Tirzepatide | From $249/mo (starting dose, compounded) | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Multi-state |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
GOAL.MD
GOAL.MD is a St. Louis-based telehealth platform offering compounded semaglutide alongside brand-name bridges to Ozempic, Wegovy, and Zepbound. Its standout is a manual-renewal model — no auto-billing
Why it's a deal
- Transparent dose-tiered pricing on brand pens
- LegitScript Certified
- Manual-renewal model — no surprise auto-billing
- Free nutrition coach included
- BBB A+ rating since 2021
The fine print
- No named compounding pharmacy partner
- Co-founder and chief physician has a 2016 federal guilty plea for distributing misbranded HGH and a (reinstated) license revocation
- No URAC or PCAB pharmacy accreditation
Ro
A heavyweight platform with brand-name access — but it won't show a compounded price until you're in the funnel.
Why it's a deal
- Brand-name (Wegovy/Zepbound) access and insurance support
- Oral options
- Polished, well-funded platform
The fine print
- Does not publish compounded pricing up front — no way to compare the deal
- Premium positioning
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores GOAL.MD is ranked on the GOAL.MD alternatives ranking, and the same list for the other side is on alternatives to Ro.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.